Sylvester Comprehensive Cancer Center/University of Miami Miami, Florida
Director of Breast Surgical Oncology Co-Leader of Breast Site Disease Group Medical Director, Operating Room Professor of Surgery University of Miami School of Medicine
Exploring how an individual’s neighborhood environment impacts their breast cancer development and growth.
An individual’s neighborhood impacts many aspects of their life. People living in neighborhoods with limited access to healthcare, good food, clean air and water, etc., are more likely to experience poor health outcomes. In fact, despite significant advances in breast cancer screening, diagnosis, and treatment, women living in disadvantaged compared to advantaged neighborhoods have higher breast cancer mortality rates. Drs. Kesmodel and Goel are conducting studies to examine precisely how neighborhood disadvantage influences breast cancer survival and how it impacts the tumor microenvironment (TME). Their findings will enhance our understanding of the epidemiologic and genomic links between neighborhood disadvantage and aggressive breast cancer. The team will also examine the connection between psychological stress in these neighborhoods and tumor biology. Drs. Kesmodel and Goel hope their results may pave the way for future strategies to target modifiable factors and potentially reduce the disparity in breast cancer outcomes.
Drs. Kesmodel, Goel, and their colleagues are leveraging epidemiologic and genomic data from the ongoing Miami Breast Cancer Disparities Study, a prospective longitudinal cohort study with 280 breast cancer biospecimens and validated survey data on perceived neighborhood stress. They are utilizing samples from this large and diverse cohort of patients (approximately 55 percent Hispanic, 20 percent Black, 21 percent White) to map the cellular and molecular mechanisms by which neighborhood disadvantage leads to aggressive tumor biology. In the last year, they evaluated 150 samples, specifically focusing on two proteins—CD-34 and LYVE-1—that are associated with TME aggressiveness. In addition, clinical and long-term outcome data have been collected for these 150 patients.
Drs. Kesmodel and Goel will continue to analyze the samples, focusing on specific tumor drivers correlated with disadvantaged neighborhoods. On the patient level, distribution of neighborhood surveys will be expanded to assess if higher levels of perceived stress are also associated with an aggressive TME.
Susan Kesmodel, MD is a Professor of Clinical Surgery in the Division of Surgical Oncology, Department of Surgery at the University of Miami, Miller School of Medicine. Dr. Kesmodel received her medical degree from the University of Pennsylvania, Perelman School of Medicine and completed a residency in general surgery at the Hospital of the University of Pennsylvania and a fellowship in surgical oncology at MD Anderson Cancer Center.
Dr. Kesmodel specializes in the treatment of benign and malignant breast diseases and high-risk skin malignancies including melanoma. Her clinical interests include prophylactic breast surgery for high-risk patients, oncoplastic breast surgery, and optimizing local-regional treatment for patients with breast cancer. Her main research interest is in management of the axilla in both early-stage and advanced breast cancer. Dr. Kesmodel is the Director of Breast Surgical Oncology and Co-Leader of the Breast Site Disease Group for Sylvester Comprehensive Cancer Center. She participates in the development of clinical research projects examining breast cancer management and outcomes and prospective clinical research protocols to improve patient management and reduce surgical morbidity. She also collaborates with multiple basic scientists to develop translational research protocols examining novels therapies for resistant and/or aggressive breast cancer subtypes. Dr. Kesmodel also serves as the Chair for the Commission on Cancer at Sylvester Comprehensive Cancer Center.
Dr. Kesmodel has authored numerous articles on breast cancer management and outcomes. She is a member of the Society of Surgical Oncology where she serves on the Breast Disease Site Working Group, American Society of Breast Surgeons, and the American College of Surgeons. Dr. Kesmodel is committed to education and is a Vice-Chair for the Continuous Certification Assessment (CCA) for the American Board of Surgery and leads the Breast Committee where she oversees development of questions for the CCA exam.
2024
The AutoNation and Dolphins Cancer Challenge Award
Support research with a legacy gift. Sample, non-binding bequest language:
I give to the Breast Cancer Research Foundation, located in New York, NY, federal tax identification number 13-3727250, ________% of my total estate (or $_____).
Stay in the know with the latest research news, insights, and resources delivered to your inbox.
Follow BCRF on all the major platforms for research news, inspiring stories, and more.